Papers on triple therapy

10 papers5 new in 30 days

Monday, November 9

AHA Scientific Sessions 2026 AbstractNov 9

Three-drug obesity therapy improved blood fat particle profiles

A 26-week randomized trial in adults with obesity but without type 2 diabetes found favorable changes in cholesterol-carrying particles with the three-drug combination.A 26-week randomized trial in adults with obesity but without type 2 diabetes found favorable changes in cholesterol-carrying particles with the three-drug combination.

Randomized trialObesity

Monday, October 26

ESC Congress 2026 AbstractOct 26

The effect of left bundle branch block on pharmacotherapy and changes of left ventricular ejection fraction after the rapid-up titration of guideline-directed medical therapy in heart failure

Cohort study of 89 peopleGuideline-directed medical therapy

ESC Congress 2026 AbstractOct 26

The importance of continuous up-titration and long-term application of guideline-directed medical therapy on prognosis after hospitalisation for heart failure

Cohort study of 551 peopleHeart failure

ESC Congress 2026 AbstractOct 26

Frailty in patients suffering from heart failure with reduced ejection fraction: how are pharmacotherapy and prognosis affected?

Cohort study of 237 peopleLeft ventricular ejection fraction

ESC Congress 2026 AbstractOct 26

Upfront combination lipid-lowering therapy in acute coronary syndrome: a bayesian network meta-analysis of low-density lipoprotein cholesterol reduction and major adverse cardiovascular events

Meta-analysisAcute coronary syndrome

Thursday, August 27

Nephrology, Dialysis, TransplantationAug 27

Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data

Cohort study of 19,139 peopleChronic kidney disease

Tuesday, March 24

Clinical Research in CardiologyMar 24

Revisiting the obesity paradox in patients with heart failure with reduced ejection fraction in the light of contemporary guideline-directed medical therapy

Cohort study of 420 peopleHeart failure with reduced ejection fraction

Sunday, March 8

Orvosi HetilapMar 8

Determination of albuminuria in the light of the first-line pharmacotherapy of heart failure with reduced ejection fraction

Cohort study of 186 peopleAlbuminuria

Monday, February 16

The Egyptian Heart JournalFeb 16

Safety and efficacy of triple combination therapy in hypertension and dyslipidemia: a systematic review and meta-analysis of randomized controlled trials

Meta-analysis of randomized trialsDyslipidemia

Thursday, May 26

PharmacotherapyMay 26

Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling

Cohort study of 5,314 peopleHyperlipidemia